Speciality Medicines IPO Subscription
The Speciality Medicines IPO subscription reflects the demand received from different investor categories during the bidding period. The subscription data includes the number of shares offered, shares bid for, and the subscription multiple (X) for categories such as Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), and Retail Individual Investors (RIIs).
As per the latest subscription update, the Speciality Medicines IPO has received bids for 73,31,000 shares against 32,89,000 shares offered, resulting in an overall subscription of 2.23x. the NII category is subscribed 2.01x, Retail Investors 0.85x, and QIBs 96.24x. Within the NII category, BNII is subscribed 2.7x, while SNII is subscribed 0.64x.
- Retail
- 0.85x
- NII
- 2.01x
- QIB
- 96.24x
- Total
- 2.23x
Current GMP
₹0 (0.00%)
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
Speciality Medicines IPO Subscription Details ( Tue, 24 Mar 26 01:59 PM)
| Category | Shares Offered | Shares Bid For | Subscription (x) |
|---|---|---|---|
| Qualified Institutions | 21,000 | 2,021,000 | 96.24x |
| Non-Institutional | 1,089,000 | 2,194,000 | 2.01x |
| BNII (>₹10L) | 726,000 | 1,963,000 | 2.7x |
| SNII (₹2L–₹10L) | 363,000 | 231,000 | 0.64x |
| Retail Investors | 1,090,000 | 922,000 | 0.85x |
| Total | 3,289,000 | 7,331,000 | 2.23x |
Subscription figures are updated periodically and may change until issue closing. Data reflects bids placed across exchanges.
Application Wise Breakup (Approximate)
| Category | Reserved Apps | Applied Apps | Times (x) |
|---|---|---|---|
| Non-Institutional | 363 | 222 | 0.61x |
| BNII (>₹10L) | 242 | 167 | 0.69x |
| SNII (₹2L–₹10L) | 121 | 55 | 0.45x |
| Retail Investors | 545 | 461 | 0.85x |
Subscription figures are updated periodically and may change until issue closing. Data reflects bids placed across exchanges.
Shares bids Against Offered
Disclaimer: This data is for informational purposes only and does not constitute investment advice.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Where Can I Check the Speciality Medicines IPO Live Subscription Status?
You can check the Speciality Medicines IPO live subscription status on the IPO Master App or the official websites of the BSE. The live subscription data is updated regularly during the IPO bidding period and displays category-wise subscription figures for Retail Individual Investors (RII), Non-Institutional Investors (NII), Qualified Institutional Buyers (QIB), Employees (if applicable), and the overall IPO subscription.
What is Speciality Medicines IPO retail subscription status?
The Retail Individual Investor (RII) portion of the Speciality Medicines IPO was subscribed 0.85 times as of Tue, Mar 24, 2026 07:29 PM. The public issue closed on Tue, Mar 24, 2026 for bidding.
How to subscribe Speciality Medicines IPO?
Investors can apply for the Speciality Medicines IPO online through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or via UPI using a SEBI-registered stockbroker or trading app. Select the desired lot size, enter your bid within the price band, and submit your application during the IPO subscription period. The application amount remains blocked in your bank account until the IPO allotment process is completed.
How many times Speciality Medicines IPO subscribed?
The Speciality Medicines IPO was subscribed 2.23x times at the close of bidding period on Tue, Mar 24, 2026.
How to check Speciality Medicines IPO allotment?
The Speciality Medicines IPO allotment was finalized on Wed, Mar 25, 2026. You can check the Speciality Medicines IPO allotment status on the registrar's website or the BSE/NSE websites using your PAN, application number, or DP/Client ID. You can also check the allotment status quickly through the IPO Master App.
When Will the Speciality Medicines IPO Be Listed?
The Speciality Medicines IPO was listed on Mon, Mar 30, 2026, on the BSE.
What is the Speciality Medicines IPO Qualified Institutional Buyers (QIB) subscription status?
The Qualified Institutional Buyers (QIB) category of Speciality Medicines IPO was subscribed 96.24 times as of Tue, Mar 24, 2026 07:29 PM.